BI 2536

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
90061
Multicenter parallel phase II trial of BI 2536 administrered as one hour i.v. infusion every 3 weeks in defined cohorts of patients with various solid tumors. A new drug screening program of the EORTC Network of Core Institutions (NOCI)

Back to Protocol section